Conversely, in the context of established HCC, short-term stimulation of the cGAS-STING cascade has demonstrated the ability to diminish tumor load in advanced HCC and reconfigure the TME, thereby augmenting anti-tumor immunity. The gene discussed is CGAS; the disease is hepatocellular carcinoma.